Before the advent of multiagent chemotherapy, the prognosis for patients with Stage IV neuroblastoma of all ages was dismal. More recently, marked improvement in infants with Stage IV neuroblastoma has been reported. Twentyfour infants with Stage IV neuroblastoma have been treated at the Dana-Farber
Pediatric stage IV Hodgkin disease long-term survival
β Scribed by Stephen B. Bader; Howard Weinstein; Peter Mauch; Barbara Silver; Nancy J. Tarbell
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 671 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Survival of patients with stage iv (based on general rules established by the japanese research society for gastric cancer) gastric carcinoma often is unfavorable. among patients with a poor prognosis, a few do survive > 5 years. the authors examined pathologic and biologic features
Background. The therapeutic management in patients with stage IV Hodgkin disease is still controversial. Procedure. Among 783 children with Hodgkin disease treated from 1971 to 1996, 56 patients (7.3%) were diagnosed with stage IV. The treatment consisted of MVPP or MVPP/B-DOPA chemotherapy combined
## Abstract Patterns of care for Hodgkin's disease in the United States were surveyed through voluntary audits of hospitals with cancer programs nonapproved and approved by the Cancer Commission of the American College of Surgeons. Four hundred and seventyβthree hospitals reported 6,345 patients di
Background: the overall outcome of patients with HIV-related non-Hodgkin's lymphomas (HIV-NHL) is poor because of the adverse clinico-pathological features of HIV-NHL and of the underlying HIV infection. However, the experience of physicians in the management of HIV-NHL has increased, in particular